What is HEPACART?
HEPACART operates at the critical intersection of healthcare infrastructure and environmental safety. The company provides sophisticated dust containment and infection control systems specifically engineered for hospital renovation and maintenance projects. By facilitating compliance with Infection Control Risk Assessment (ICRA) guidelines, HEPACART enables contractors and healthcare facility managers to maintain sterile environments while improving operational productivity. Their product suite is essential for mitigating airborne contaminants in high-risk clinical settings, positioning the firm as a vital partner in modern hospital facility management and patient safety initiatives.
How much funding has HEPACART raised?
HEPACART has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in HEPACART
PPP
Public-Private Partnership
What's next for HEPACART?
With this late-stage capital, HEPACART is well-positioned to expand its footprint in the healthcare construction sector. The strategic focus will likely shift toward scaling manufacturing capabilities and enhancing the technological integration of their containment systems. As hospitals continue to prioritize infection prevention, the demand for robust, compliant, and efficient dust abatement solutions is expected to rise. The company is poised to leverage this investment to solidify its leadership in the environmental control market, potentially exploring new product lines that address emerging challenges in clinical facility maintenance and long-term infrastructure resilience.
See full HEPACART company page
